• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

联用认知增强剂(多奈哌齐)增强非典型抗精神病药物对精神分裂症患者脑区活动的改善作用:一项双盲安慰剂对照的BOLD功能磁共振成像初步研究

Augmenting atypical antipsychotics with a cognitive enhancer (donepezil) improves regional brain activity in schizophrenia patients: a pilot double-blind placebo controlled BOLD fMRI study.

作者信息

Nahas Ziad, George Mark S, Horner Michael D, Markowitz John S, Li Xingbao, Lorberbaum Jeffrey P, Owens Susan D, McGurk Susan, DeVane Lindsay, Risch S Craig

机构信息

Brain Stimulation Laboratory, Center for Advanced Imaging Research, Department of Psychiatry, Medical University of South Carolina, Charleston, SC 29425, USA.

出版信息

Neurocase. 2003 Jun;9(3):274-82. doi: 10.1076/neur.9.3.274.15563.

DOI:10.1076/neur.9.3.274.15563
PMID:12925933
Abstract

Cognitive impairments are cardinal features of schizophrenia and predictors of poor vocational and social outcome. Imaging studies with verbal fluency tasks (VFT) lead some to suggest that in schizophrenia, the combination of a failure to deactivate the left temporal lobe and a hypoactive frontal lobe reflects a functional disconnectivity between the left prefrontal cortex and temporal lobe. Others have theorized that an abnormal cingulate gyrus modulates such fronto-temporal connectivity. Thus addition of a cognitive enhancing medication to current antipsychotic therapy might improve functionality of networks necessary in working memory and internal concept generation. To test this hypothesis, we serially measured brain activity in 6 subjects on stable atypical antipsychotics performing a VFT, using BOLD fMRI. Measurements were made at baseline and again after groups were randomized to receive 12 weeks of donepezil (an acetylcholinesterase inhibitor) and placebo in a blind cross-over design. Donepezil addition provided a functional normalization with an increase in left frontal lobe and cingulate activity when compared to placebo and from baseline scans. This pilot study supports the cingulate's role in modulating cognition and neuronal connectivity in schizophrenia.

摘要

认知障碍是精神分裂症的主要特征,也是职业和社会结局不佳的预测因素。使用言语流畅性任务(VFT)的影像学研究使一些人认为,在精神分裂症中,左颞叶失活失败与额叶活动减退相结合反映了左前额叶皮层与颞叶之间的功能断开连接。其他人则推测异常的扣带回调节这种额颞连接。因此,在当前的抗精神病治疗中添加认知增强药物可能会改善工作记忆和内部概念生成所需网络的功能。为了验证这一假设,我们使用BOLD功能磁共振成像对6名服用稳定非典型抗精神病药物并执行VFT的受试者的大脑活动进行了连续测量。在基线时进行测量,并在将各组随机分配接受12周多奈哌齐(一种乙酰胆碱酯酶抑制剂)和安慰剂的盲法交叉设计后再次测量。与安慰剂和基线扫描相比,添加多奈哌齐可使左额叶和扣带回活动增加,从而实现功能正常化。这项初步研究支持扣带回在调节精神分裂症认知和神经元连接中的作用。

相似文献

1
Augmenting atypical antipsychotics with a cognitive enhancer (donepezil) improves regional brain activity in schizophrenia patients: a pilot double-blind placebo controlled BOLD fMRI study.联用认知增强剂(多奈哌齐)增强非典型抗精神病药物对精神分裂症患者脑区活动的改善作用:一项双盲安慰剂对照的BOLD功能磁共振成像初步研究
Neurocase. 2003 Jun;9(3):274-82. doi: 10.1076/neur.9.3.274.15563.
2
Effects of donepezil adjunctive treatment to ziprasidone on cognitive deficits in schizophrenia: a double-blind, placebo-controlled study.多奈哌齐辅助齐拉西酮治疗对精神分裂症认知缺陷的影响:一项双盲、安慰剂对照研究。
Clin Neuropharmacol. 2007 Jan-Feb;30(1):3-12. doi: 10.1097/01.WNF.0000240940.67241.F6.
3
A 12-week, double-blind, placebo-controlled trial of donepezil as an adjunct to haloperidol for treating cognitive impairments in patients with chronic schizophrenia.一项为期12周的双盲、安慰剂对照试验,评估多奈哌齐作为氟哌啶醇辅助药物治疗慢性精神分裂症患者认知障碍的疗效。
J Psychopharmacol. 2007 Jun;21(4):421-7. doi: 10.1177/0269881106070996. Epub 2006 Nov 8.
4
A 12-week, double-blind, placebo-controlled trial of donepezil adjunctive treatment to risperidone in chronic and stable schizophrenia.一项为期12周的多奈哌齐辅助利培酮治疗慢性稳定型精神分裂症的双盲、安慰剂对照试验。
Prog Neuropsychopharmacol Biol Psychiatry. 2008 Dec 12;32(8):1810-5. doi: 10.1016/j.pnpbp.2008.08.001. Epub 2008 Aug 7.
5
Neural correlates of adjunctive rivastigmine treatment to antipsychotics in schizophrenia: a randomized, placebo-controlled, double-blind fMRI study.精神分裂症中加用卡巴拉汀辅助抗精神病药物治疗的神经关联:一项随机、安慰剂对照、双盲功能磁共振成像研究
Neuroimage. 2006 Jan 15;29(2):545-56. doi: 10.1016/j.neuroimage.2005.08.013. Epub 2005 Sep 21.
6
Donepezil augmentation of clozapine monotherapy in schizophrenia patients: a double blind cross-over study.多奈哌齐增强氯氮平单药治疗精神分裂症患者:一项双盲交叉研究。
Hum Psychopharmacol. 2004 Jul;19(5):343-6. doi: 10.1002/hup.595.
7
A double-blind study of combination of clozapine with risperidone in patients with schizophrenia: effects on cognition.氯氮平与利培酮联合治疗精神分裂症患者的双盲研究:对认知的影响。
J Clin Psychiatry. 2006 Dec;67(12):1912-9.
8
Double-blind donepezil-placebo crossover augmentation study of atypical antipsychotics in chronic, stable schizophrenia: a pilot study.非典型抗精神病药物用于慢性稳定型精神分裂症的双盲多奈哌齐-安慰剂交叉增效研究:一项试点研究
Schizophr Res. 2007 Jul;93(1-3):131-5. doi: 10.1016/j.schres.2007.01.001. Epub 2007 Mar 27.
9
A randomized, double-blind, placebo-controlled trial of donepezil to improve memory in epilepsy.一项关于多奈哌齐改善癫痫患者记忆力的随机、双盲、安慰剂对照试验。
Epilepsia. 2007 Jul;48(7):1283-91. doi: 10.1111/j.1528-1167.2007.01114.x. Epub 2007 May 1.
10
A 12-week, double-blind, placebo-controlled trial of galantamine adjunctive treatment to conventional antipsychotics for the cognitive impairments in chronic schizophrenia.一项为期12周的双盲、安慰剂对照试验,评估加兰他敏辅助传统抗精神病药物治疗慢性精神分裂症认知障碍的效果。
Int Clin Psychopharmacol. 2007 Mar;22(2):63-8. doi: 10.1097/YIC.0b013e3280117feb.

引用本文的文献

1
Sceletium for Managing Anxiety, Depression and Cognitive Impairment: A Traditional Herbal Medicine in Modern-Day Regulatory Systems.西芹素在焦虑、抑郁和认知障碍管理中的应用:现代监管体系中的一种传统草药。
Curr Neuropharmacol. 2021;19(9):1384-1400. doi: 10.2174/1570159X19666210215124737.
2
Effect of Pharmacological Interventions on the Fronto-Cingulo-Parietal Cognitive Control Network in Psychiatric Disorders: A Transdiagnostic Systematic Review of fMRI Studies.药物干预对精神疾病额-扣带回-顶叶认知控制网络的影响:功能磁共振成像研究的跨诊断系统评价
Front Psychiatry. 2016 May 18;7:82. doi: 10.3389/fpsyt.2016.00082. eCollection 2016.
3
Going up in smoke? A review of nAChRs-based treatment strategies for improving cognition in schizophrenia.
化为乌有?基于烟碱型乙酰胆碱受体改善精神分裂症认知的治疗策略综述
Curr Pharm Des. 2014;20(31):5077-92. doi: 10.2174/1381612819666131216121019.
4
Acetylcholinesterase inhibitors for schizophrenia.用于治疗精神分裂症的乙酰胆碱酯酶抑制剂。
Cochrane Database Syst Rev. 2012 Jan 18;1(1):CD007967. doi: 10.1002/14651858.CD007967.pub2.
5
Cognitive control deficits in schizophrenia: mechanisms and meaning.精神分裂症中的认知控制缺陷:机制与意义。
Neuropsychopharmacology. 2011 Jan;36(1):316-38. doi: 10.1038/npp.2010.156. Epub 2010 Sep 15.
6
Impact of cognitive performance on the reproducibility of fMRI activation in schizophrenia.认知表现对精神分裂症 fMRI 激活可重复性的影响。
J Psychiatry Neurosci. 2010 Nov;35(6):378-89. doi: 10.1503/jpn.090103.
7
Cholinesterase inhibitors as adjunctive therapy in patients with schizophrenia and schizoaffective disorder: a review and meta-analysis of the literature.胆碱酯酶抑制剂作为精神分裂症和分裂情感障碍患者的辅助治疗:文献综述和荟萃分析。
CNS Drugs. 2010 Apr;24(4):303-17. doi: 10.2165/11530260-000000000-00000.
8
Patterns of anterior cingulate activation in schizophrenia: a selective review.精神分裂症前扣带回激活模式:选择性综述。
Neuropsychiatr Dis Treat. 2007 Feb;3(1):87-101. doi: 10.2147/nedt.2007.3.1.87.
9
[Therapy of cognitive deficits in schizophrenia with acetylcholinesterase inhibitors. A systematic overview].[乙酰胆碱酯酶抑制剂治疗精神分裂症认知缺陷的系统综述]
Nervenarzt. 2008 Jan;79(1):47-8, 50-2, 54-9. doi: 10.1007/s00115-007-2358-1.
10
Molecular targets for treating cognitive dysfunction in schizophrenia.治疗精神分裂症认知功能障碍的分子靶点。
Schizophr Bull. 2007 Sep;33(5):1100-19. doi: 10.1093/schbul/sbm074. Epub 2007 Jul 7.